Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kassiou

Showing results (81-90 of 231) with videos related to

Pageof 24
Sort By:
Organic & Biomolecular Chemistry|December 20, 2016
Rapid access to N-(indol-2-yl)amides and N-(indol-3-yl)amides as unexplored pharmacophoresTristan A Reekie, Shane M Wilkinson, Vivian Law, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 24, 2016
Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastomaEryn L Werry, Victoria A King, Melissa L Barron, et al.
Molecular Imaging and Biology|July 12, 2017
Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict NeurodegenerationLien Beckers, Dieter Ory, Ivana Geric, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Structure-activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptorsCorinne Beinat, Samuel D Banister, Jane Hoban, et al.
Bioorganic & Medicinal Chemistry|May 3, 2005
Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptorsMichael Kassiou, Robert F Dannals, Xiang Liu, et al.
Nuclear Medicine and Biology|April 4, 2002
(+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PETMichael Kassiou, Christian Loc'h, Michel Bottlaender, et al.
Trends in Pharmacological Sciences|October 17, 2024
Enhancing CNS mitophagy: drug development and disease-relevant modelsKrishayant S Dhar, Brendan Townsend, Andrew P Montgomery, et al.
European Journal of Pharmacology|November 23, 2006
Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effectsXiang Liu, Samuel D Banister, MacDonald J Christie, et al.
Molecular Imaging and Biology|March 31, 2009
[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitisJanine Doorduin, Hans C Klein, Rudi A Dierckx, et al.
ACS Chemical Neuroscience|April 16, 2019
O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative DiseasePhilip Ryan, Mingming Xu, Andrew K Davey, et al.
Pageof 24

Showing results (81-90 of 231) with videos related to

Sort By:
Pageof 24
Organic & Biomolecular Chemistry|December 20, 2016
Rapid access to N-(indol-2-yl)amides and N-(indol-3-yl)amides as unexplored pharmacophoresTristan A Reekie, Shane M Wilkinson, Vivian Law, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 24, 2016
Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastomaEryn L Werry, Victoria A King, Melissa L Barron, et al.
Molecular Imaging and Biology|July 12, 2017
Increased Expression of Translocator Protein (TSPO) Marks Pro-inflammatory Microglia but Does Not Predict NeurodegenerationLien Beckers, Dieter Ory, Ivana Geric, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2014
Structure-activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptorsCorinne Beinat, Samuel D Banister, Jane Hoban, et al.
Bioorganic & Medicinal Chemistry|May 3, 2005
Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptorsMichael Kassiou, Robert F Dannals, Xiang Liu, et al.
Nuclear Medicine and Biology|April 4, 2002
(+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PETMichael Kassiou, Christian Loc'h, Michel Bottlaender, et al.
Trends in Pharmacological Sciences|October 17, 2024
Enhancing CNS mitophagy: drug development and disease-relevant modelsKrishayant S Dhar, Brendan Townsend, Andrew P Montgomery, et al.
European Journal of Pharmacology|November 23, 2006
Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effectsXiang Liu, Samuel D Banister, MacDonald J Christie, et al.
Molecular Imaging and Biology|March 31, 2009
[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitisJanine Doorduin, Hans C Klein, Rudi A Dierckx, et al.
ACS Chemical Neuroscience|April 16, 2019
O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative DiseasePhilip Ryan, Mingming Xu, Andrew K Davey, et al.
Pageof 24